ARMP — Armata Pharmaceuticals, Inc.

Healthcare • Biotechnology

$7.05

▲ 3.58 (—%)

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.

Insider Activity Congress Trades Company Site ↗

Company

Ticker: ARMP
Exchange
Sector: Healthcare
Industry: Biotechnology
Country: US
CEO: Deborah L. Birx
Employees: 60
Website: www.armatapharma.com

Price

3M 1Y 5Y ALL

Showing 1Y history. Source: FMP “historical price full”.

Prev Close: $3.47
Day High: $16.34
Day Low: $3.47
52w High: $16.34
52w Low: $0.90
Volume: 12,910,176
Avg Volume
Beta: 1.134

Key Metrics

Market Cap: 255M
P/E
P/B
P/S
EV/EBITDA
ROE
Net Margin
Div Yield
FCF/Share

* TTM/most recent where available